account_balance
Investment manager · 13F filer · SEC CIK 2052213
Elmind Capital, LP
Reported value$398Mas of Jun 30, 2026
Positions35 5 new, 4 sold out
Top 10 weight66.6%COGT alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
COGTCogent Biosciences, Inc.
11.4%
SNDXSyndax Pharmaceuticals Inc
10.2%
CLDXCelldex Therapeutics, Inc.
9.3%Added +14%
RLAYRelay Therapeutics, Inc.
6.9%Added +173%
PCVXVaxcyte, Inc.
6.6%Added +43%
VERAVera Therapeutics, Inc.
4.7%Trimmed −10%
PHVSPharvaris N.V.
4.6%+11%
VRDNViridian Therapeutics, Inc.
4.5%Added +84%
CTMXCytomX Therapeutics, Inc.
4.3%
TVTXTravere Therapeutics, Inc.
4.2%Added +65%
LEGNLegend Biotech Corp
4.1%New
BEAMBeam Therapeutics Inc.
4.1%
COGTCogent Biosciences, Inc.
11.4%
SNDXSyndax Pharmaceuticals Inc
10.2%
CLDXCelldex Therapeutics, Inc.
9.3%Added +14%
RLAYRelay Therapeutics, Inc.
6.9%Added +173%
PCVXVaxcyte, Inc.
6.6%+43%
VERAVera Therapeutics, Inc.
4.7%
PHVSPharvaris N.V.
4.6%
VRDNViridian Therapeutics, Inc.
4.5%
CTMXCytomX Therapeutics, Inc.
4.3%
TVTX4.2%LEGN4.1%BEAMBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
COGT Cogent Biosciences, Inc. 11.4% HeldSNDX Syndax Pharmaceuticals Inc 10.2% HeldCLDX Celldex Therapeutics, Inc. 9.3% Added +14%RLAY Relay Therapeutics, Inc. 6.9% Added +173%PCVX Vaxcyte, Inc. 6.6% Added +43%VERA Vera Therapeutics, Inc. 4.7% Trimmed −10%PHVS Pharvaris N.V. 4.6% Added +11%VRDN Viridian Therapeutics, Inc. 4.5% Added +84%CTMX CytomX Therapeutics, Inc. 4.3% HeldTVTX Travere Therapeutics, Inc. 4.2% Added +65%LEGN Legend Biotech Corp 4.1% NewBEAM Beam Therapeutics Inc. 4.1% Held
What changed
Biggest moves since Mar 31, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.